search
Back to results

Effect of Pectoralis Block on Analgesia After Simple Mastectomy

Primary Purpose

Mastectomy, Nerve Block, Analgesia, Postoperative

Status
Withdrawn
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Pectoralis block
Normal saline injection
Ropivacaine Injection
Sponsored by
Vanderbilt University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mastectomy focused on measuring Ropivacaine

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA 1, 2, and 3 patients (According to ASA classification of comorbid conditions and general health)
  • Patients undergoing simple mastectomy

Exclusion Criteria:

  • -Patient Refusal
  • Allergy to local anesthetics
  • Inability to communicate in English
  • Use of 8 mg morphine equivalents or greater currently and for a period of longer then 2 weeks prior to surgery
  • Existing nerve injuries or sensory deficits
  • Conversion to anesthesia via an endotracheal tube

Sites / Locations

  • Vanderbilt University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Pectoralis Block with Ropivacaine

Pectoralis Block with normal saline

Arm Description

General anesthesia + pectoralis block with ropivacaine injection 30ml of 0.25% (75mg)

General anesthesia + Pectoralis block with 30ml of normal saline injection

Outcomes

Primary Outcome Measures

Quality of Recovery-27 score at baseline
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery at baseline
Quality of Recovery-27 score at post operative day 1
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 1
Quality of Recovery-27 scores at post operative day 7
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 7
Quality of Recovery-27 scores at post operative day 30
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 30
Quality of Recovery-27 scores at post operative day 90
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 90

Secondary Outcome Measures

Comparison of Numerical Rating Scale-11 (NRS-11) at rest
Comparison of patient reported pain assessment while at rest using the NRS-11 Scale at arrival in PACU, 15 minutes, 30 minutes, 1 hour and 2 hours after arrival in PACU, and postoperative days 1, 7, 30, and 90. The NRS-11 is a 11 point scale when 0 is no pain and 10 is severe pain.
Comparison of Numerical Rating Scale-11 (NRS-11) with movement
Comparison of patient reported pain assessment while with movement using the NRS-11 Scale at arrival in PACU, 15 minutes, 30 minutes, 1 hour and 2 hours after arrival in PACU, and postoperative days 1, 7, 30, and 90. The NRS-11 is a 11 point scale when 0 is no pain and 10 is severe pain.
Duration of postoperative analgesia
Duration of postoperative analgesia as measured by time in minutes to first intravenous or oral opioid postoperatively.

Full Information

First Posted
March 20, 2017
Last Updated
August 10, 2018
Sponsor
Vanderbilt University Medical Center
Collaborators
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT03143530
Brief Title
Effect of Pectoralis Block on Analgesia After Simple Mastectomy
Official Title
The Effect of Pectoralis Block on Analgesia After Simple Mastectomy
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Extensive protocol revisions initiated.
Study Start Date
December 2017 (Anticipated)
Primary Completion Date
March 1, 2019 (Anticipated)
Study Completion Date
April 1, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University Medical Center
Collaborators
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The pectoralis block, including pecs I and II block, is a novel technique first described in 2011 as an alternative to paravertebral blockade for analgesia following breast surgery. The research goal is to determine the efficacy of the pectoralis block compared to placebo in improving quality of recovery following mastectomy.
Detailed Description
The pectoralis block, including pecs I and II block, is a novel technique first described in 2011 as an alternative to paravertebral blockade for analgesia following breast surgery. The concept involves injecting local anesthetic near the coracoid process in the fascial planes between both the pectoralis major and minor muscles (pecs I), and the fascial plane between the pectoralis minor and serratus anterior muscles (pecs II). This is a prospective, double-blinded, randomized controlled trial in subjects undergoing mastectomy under general anesthesia. The research goal is to determine the efficacy of the pectoralis block compared to placebo in improving quality of recovery following mastectomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mastectomy, Nerve Block, Analgesia, Postoperative
Keywords
Ropivacaine

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Participants will be assigned to one of two of the following groups for the duration of the study. General anesthesia + pectoralis block with Ropivacaine 30ml of 0.25% (75mg) General anesthesia + sham block with 30ml of normal saline
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Participants, care providers, investigators, and observers who record central measurements will be blinded to group allocation.
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Pectoralis Block with Ropivacaine
Arm Type
Active Comparator
Arm Description
General anesthesia + pectoralis block with ropivacaine injection 30ml of 0.25% (75mg)
Arm Title
Pectoralis Block with normal saline
Arm Type
Placebo Comparator
Arm Description
General anesthesia + Pectoralis block with 30ml of normal saline injection
Intervention Type
Procedure
Intervention Name(s)
Pectoralis block
Intervention Description
Pectoralis block involving injection near the coracoid process in the fascial planes between both the pectoralis major and minor muscles (pecs I), and the fascial plane between the pectoralis minor and serratus anterior muscles (pecs II).
Intervention Type
Drug
Intervention Name(s)
Normal saline injection
Intervention Description
Pectoralis block involving injection of normal saline 30ml near the coracoid process in the fascial planes between both the pectoralis major and minor muscles (pecs I), and the fascial plane between the pectoralis minor and serratus anterior
Intervention Type
Drug
Intervention Name(s)
Ropivacaine Injection
Intervention Description
Pectoralis block involving injection of ropivacaine injection 30ml of 0,25% (75 mg) near the coracoid process in the fascial planes between both the pectoralis major and minor muscles (pecs I), and the fascial plane between the pectoralis minor and serratus anterior
Primary Outcome Measure Information:
Title
Quality of Recovery-27 score at baseline
Description
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery at baseline
Time Frame
Baseline
Title
Quality of Recovery-27 score at post operative day 1
Description
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 1
Time Frame
Post operative day 1
Title
Quality of Recovery-27 scores at post operative day 7
Description
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 7
Time Frame
Post operative day 7
Title
Quality of Recovery-27 scores at post operative day 30
Description
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 30
Time Frame
Post operative day 30
Title
Quality of Recovery-27 scores at post operative day 90
Description
Quality of Recovery-27 score, a validated tool to assess quality of postoperative recovery, at baseline and post operative day 90
Time Frame
Post operative day 90
Secondary Outcome Measure Information:
Title
Comparison of Numerical Rating Scale-11 (NRS-11) at rest
Description
Comparison of patient reported pain assessment while at rest using the NRS-11 Scale at arrival in PACU, 15 minutes, 30 minutes, 1 hour and 2 hours after arrival in PACU, and postoperative days 1, 7, 30, and 90. The NRS-11 is a 11 point scale when 0 is no pain and 10 is severe pain.
Time Frame
90 days
Title
Comparison of Numerical Rating Scale-11 (NRS-11) with movement
Description
Comparison of patient reported pain assessment while with movement using the NRS-11 Scale at arrival in PACU, 15 minutes, 30 minutes, 1 hour and 2 hours after arrival in PACU, and postoperative days 1, 7, 30, and 90. The NRS-11 is a 11 point scale when 0 is no pain and 10 is severe pain.
Time Frame
90 days
Title
Duration of postoperative analgesia
Description
Duration of postoperative analgesia as measured by time in minutes to first intravenous or oral opioid postoperatively.
Time Frame
Up to 24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA 1, 2, and 3 patients (According to ASA classification of comorbid conditions and general health) Patients undergoing simple mastectomy Exclusion Criteria: -Patient Refusal Allergy to local anesthetics Inability to communicate in English Use of 8 mg morphine equivalents or greater currently and for a period of longer then 2 weeks prior to surgery Existing nerve injuries or sensory deficits Conversion to anesthesia via an endotracheal tube
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Uma Shastri, MD
Organizational Affiliation
Vanderbilt University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vanderbilt University Medical Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37212
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of Pectoralis Block on Analgesia After Simple Mastectomy

We'll reach out to this number within 24 hrs